The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM).
Annick Desjardins
No relevant relationships to disclose
John Howard Sampson
No relevant relationships to disclose
Katherine B. Peters
No relevant relationships to disclose
Tulika Ranjan
No relevant relationships to disclose
Gordana Vlahovic
No relevant relationships to disclose
Jason Watts
No relevant relationships to disclose
Stevie Threatt
No relevant relationships to disclose
James Emmett Herndon
No relevant relationships to disclose
Susan Boulton
No relevant relationships to disclose
Denise Lally-Goss
No relevant relationships to disclose
Frances McSherry
No relevant relationships to disclose
Allan H. Friedman
No relevant relationships to disclose
Henry S. Friedman
No relevant relationships to disclose
Darell D. Bigner
Research Funding - NCI
Matthias Gromeier
No relevant relationships to disclose